| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5949814 | Atherosclerosis | 2011 | 7 Pages |
Abstract
CETP agonism by leoligin appears to be safe and effective, and may prove to be a useful modality to alter high-density lipoprotein metabolism.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kristina Duwensee, Stefan Schwaiger, Ivan Tancevski, Kathrin Eller, Miranda van Eck, Patrick Markt, Tobias Linder, Ursula Stanzl, Andreas Ritsch, Josef R. Patsch, Daniela Schuster, Hermann Stuppner, David Bernhard, Philipp Eller,